Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Menopause affects hair and skin; more research needed for treatment.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Cognitive behavioral strategies help women with PCOS make lifestyle changes to improve their health.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Hair loss patients have different microbes in hair follicles, possibly affecting hair loss.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Acne severity in women may not be linked to increased male hormone indicators like excess body hair, menstrual irregularities, or hair loss.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.